BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 28755462)

  • 1. Exploring the screening capacity of the Fear of Cancer Recurrence Inventory-Short Form for clinical levels of fear of cancer recurrence.
    Fardell JE; Jones G; Smith AB; Lebel S; Thewes B; Costa D; Tiller K; Simard S; Feldstain A; Beattie S; McCallum M; ; Butow P
    Psychooncology; 2018 Feb; 27(2):492-499. PubMed ID: 28755462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Re-validation and screening capacity of the 6-item version of the Cancer Worry Scale.
    Custers JAE; Kwakkenbos L; van de Wal M; Prins JB; Thewes B
    Psychooncology; 2018 Nov; 27(11):2609-2615. PubMed ID: 29843189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initial validation of the Danish version of the Fear of Cancer Recurrence Inventory (FCRI) in colorectal cancer patients.
    Hovdenak Jakobsen I; Jeppesen MM; Simard S; Thaysen HV; Laurberg S; Juul T
    J Cancer Surviv; 2018 Dec; 12(6):723-732. PubMed ID: 30128857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Examining the dimensionality of the Fear of Cancer Recurrence Inventory.
    Galica J; Brennenstuhl S; Maheu C; Townsley C; Metcalfe K
    Psychooncology; 2018 Nov; 27(11):2602-2608. PubMed ID: 29998546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical, demographic and psychological correlates of fear of cancer recurrence (FCR) morbidity in breast, colorectal and melanoma cancer survivors with probable clinically significant FCR seeking psychological treatment through the ConquerFear study.
    Smith A'; Sharpe L; Thewes B; Turner J; Gilchrist J; Fardell JE; Girgis A; Tesson S; Descallar J; Bell ML; Beith J; Butow P;
    Support Care Cancer; 2018 Dec; 26(12):4207-4216. PubMed ID: 29882025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measuring fear of cancer recurrence in survivors of childhood cancer: Development and preliminary validation of the Fear of Cancer Recurrence Inventory (FCRI)-Child and Parent versions.
    Tutelman PR; Chambers CT; Heathcote LC; Fernandez CV; Flanders A; Patton M; Schulte FSM; Guilcher GMT; Simard S; MacLeod J; Stern M
    Psychooncology; 2022 Jun; 31(6):911-919. PubMed ID: 35018689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validity and screening capacity of the FCR-1r for fear of cancer recurrence in long-term colorectal cancer survivors.
    Lyhne JD; Smith AB; Timm S; Simard S; Jensen LH; Frostholm L; Fink P
    Support Care Cancer; 2023 Nov; 31(12):690. PubMed ID: 37950072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ConquerFear-Group: A randomized controlled trial of an online-delivered group-based psychological intervention for fear of cancer recurrence in breast cancer survivors.
    Tauber NM; O'Toole MS; Jensen AB; Butow PN; Thewes B; Elkjaer E; Knutzen S; von Heymann A; Johansen C; Zachariae R
    Psychooncology; 2023 Sep; 32(9):1424-1432. PubMed ID: 37489745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening and comorbidity of clinical levels of fear of cancer recurrence.
    Simard S; Savard J
    J Cancer Surviv; 2015 Sep; 9(3):481-91. PubMed ID: 25603948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the validity and screening performance of a revised single-item fear of cancer recurrence screening measure (FCR-1r).
    Smith A'; Gao M; Tran M; Ftanou M; Jegathees S; Wu V; Jefford M; Lynch F; Dhillon HM; Shaw J; McDowell L; White A; Halloran C; Wiesenfeld D; Bamgboje-Ayodele A
    Psychooncology; 2023 Jun; 32(6):961-971. PubMed ID: 37120796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fear of cancer recurrence among Chinese cancer survivors: Prevalence and associations with metacognition and neuroticism.
    Ng DWL; Kwong A; Suen D; Chan M; Or A; Ng SS; Foo CC; Fielding BFS; Lam WWT
    Psychooncology; 2019 Jun; 28(6):1243-1251. PubMed ID: 30932279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Empirical validation of the English version of the Fear of Cancer Recurrence Inventory.
    Lebel S; Simard S; Harris C; Feldstain A; Beattie S; McCallum M; Lefebvre M; Savard J; Devins GM
    Qual Life Res; 2016 Feb; 25(2):311-321. PubMed ID: 26341969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards the validation of a new, blended theoretical model of fear of cancer recurrence.
    Lebel S; Maheu C; Tomei C; Bernstein LJ; Courbasson C; Ferguson S; Harris C; Jolicoeur L; Lefebvre M; Muraca L; Ramanakumar AV; Singh M; Parrott J; Figueiredo D
    Psychooncology; 2018 Nov; 27(11):2594-2601. PubMed ID: 30180279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized Trial of ConquerFear: A Novel, Theoretically Based Psychosocial Intervention for Fear of Cancer Recurrence.
    Butow PN; Turner J; Gilchrist J; Sharpe L; Smith AB; Fardell JE; Tesson S; O'Connell R; Girgis A; Gebski VJ; Asher R; Mihalopoulos C; Bell ML; Zola KG; Beith J; Thewes B
    J Clin Oncol; 2017 Dec; 35(36):4066-4077. PubMed ID: 29095681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilization of health care services in cancer patients with elevated fear of cancer recurrence.
    Champagne A; Ivers H; Savard J
    Psychooncology; 2018 Aug; 27(8):1958-1964. PubMed ID: 29719072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychometric evaluation of the Fear of Cancer Recurrence Inventory (FCRI) and development of a short version in patients with follicular lymphoma.
    Xu RH; Yu S; Yang Y; Ng S; Xu B; Dong D
    Disabil Rehabil; 2022 Dec; 44(24):7508-7515. PubMed ID: 34623949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spotlight on the Fear of Cancer Recurrence Inventory (FCRI).
    Smith AB; Costa D; Galica J; Lebel S; Tauber N; van Helmondt SJ; Zachariae R
    Psychol Res Behav Manag; 2020; 13():1257-1268. PubMed ID: 33376421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The FCR-1: Initial validation of a single-item measure of fear of cancer recurrence.
    Rudy L; Maheu C; Körner A; Lebel S; Gélinas C
    Psychooncology; 2020 Apr; 29(4):788-795. PubMed ID: 32026563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lived Experiences and Fear of Cancer Recurrence Among Survivors of Localized Cutaneous Melanoma.
    Mahama AN; Haller CN; Labrada J; Idiong CI; Haynes AB; Jacobs EA; Tsevat J; Pignone MP; Adamson AS
    JAMA Dermatol; 2024 May; 160(5):495-501. PubMed ID: 38353983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fear of cancer recurrence in young early-stage breast cancer survivors: the role of metacognitive style and disease-related factors.
    Thewes B; Bell ML; Butow P
    Psychooncology; 2013 Sep; 22(9):2059-63. PubMed ID: 23408595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.